Product details

By continuing to use our site you consent to the use of cookies as described in our privacy policy unless you have disabled them.
You can change your cookie settings at any time but parts of our site will not function correctly without them.
Case
-
Reference no. 9B02N014
Published by: Ivey Publishing
Originally published in: 2002
Version: 2006-02-14
Length: 25 pages
Data source: Field research

Abstract

Merix Bioscience is a biotechnology company that researches and develops cancer vaccines. An investment analyst for a venture capital fund must evaluate whether or not to recommend participation in a second round of financing for the company. The analyst must assess the company''s strengths and weaknesses, the value of shares and determine the key clauses of the term sheet.
Location:
Size:
Small
Other setting(s):
2001

About

Abstract

Merix Bioscience is a biotechnology company that researches and develops cancer vaccines. An investment analyst for a venture capital fund must evaluate whether or not to recommend participation in a second round of financing for the company. The analyst must assess the company''s strengths and weaknesses, the value of shares and determine the key clauses of the term sheet.

Settings

Location:
Size:
Small
Other setting(s):
2001

Related